SCHEMBL13554129

SCHEMBL13554129

c1ccc(-c2cc(-c3ccc4c(c3)c3ccccc3n4-c3ccccc3)cc(-c3ccccc3)n2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.53
KDM4E B2RXH2 2/20 0.53
ATM Q13315 1/20 0.53
PTGER4 P35408 1/20 0.41
KMT2A Q03164 5/20 0.38
IL1R1 P14778 1/20 0.38
NPY5R Q15761 2/20 0.38
TSPO P30536 1/20 0.38
MEN1 O00255 4/20 0.38
ALDH1A1 P00352 3/20 0.38
MAPT P10636 3/20 0.38
HTT P42858 1/20 0.38
ACHE P22303 1/20 0.37
CYP19A1 P11511 1/20 0.37
DHODH Q02127 1/20 0.36
PTGES O14684 1/20 0.36
MAPK1 P28482 2/20 0.36
TDP1 Q9NUW8 2/20 0.36
NPC1 O15118 1/20 0.36
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12162422 0.99 L3MBTL1 (0.51) L3MBTL1KDM4EATMPTGER4KMT2A
SCHEMBL13554130 0.99 L3MBTL1 (0.51) L3MBTL1KDM4EATMPTGER4KMT2A
SCHEMBL21973897 0.99 L3MBTL1 (0.51) L3MBTL1KDM4EATMPTGER4KMT2A
SCHEMBL17228151 0.97 L3MBTL1 (0.50) L3MBTL1KDM4EATMPTGER4KMT2A
SCHEMBL6373210 0.97 L3MBTL1 (0.50) L3MBTL1KDM4EATMPTGER4KMT2A
SCHEMBL6374096 0.97 L3MBTL1 (0.50) L3MBTL1KDM4EATMPTGER4KMT2A
SCHEMBL6374944 0.97 L3MBTL1 (0.50) L3MBTL1KDM4EATMPTGER4KMT2A
SCHEMBL17228150 0.97 L3MBTL1 (0.50) L3MBTL1KDM4EATMPTGER4KMT2A
SCHEMBL14748726 0.97 L3MBTL1 (0.50) L3MBTL1KDM4EATMPTGER4KMT2A
SCHEMBL6373006 0.97 L3MBTL1 (0.50) L3MBTL1KDM4EATMPTGER4KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120267620-A1 COMPOUND FOR ORGANIC PHOTOELECTRIC DEVICE, ORGANIC PHOTOELECTRIC DEVICE INCLUDING THE SAME, AND DISPLAY DEVICE INCLUDING THE ORGANIC PHOTOELECTRIC DEVICE CHEIL INDUSTRIES, INC. (KR) 2012-10-25 US disclosed
US-20120267620-A1 COMPOUND FOR ORGANIC PHOTOELECTRIC DEVICE, ORGANIC PHOTOELECTRIC DEVICE INCLUDING THE SAME, AND DISPLAY DEVICE INCLUDING THE ORGANIC PHOTOELECTRIC DEVICE CHEIL INDUSTRIES, INC. (KR) 2012-10-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120267620-A1 COMPOUND FOR ORGANIC PHOTOELECTRIC DEVICE, ORGANIC PHOTOELECTRIC DEVICE INCLUDING THE SAME, AND DISPLAY DEVICE INCLUDING THE ORGANIC PHOTOELECTRIC DEVICE PPOX, AOX1, PNPO L3MBTL1 4094/4885KDM4E 1649/4885ATM 3669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.